John Moller

John Russell Moller is Chief Executive Officer at Novotech Clinical Research Usa, Inc. (Massachusetts) since 2014.
He is Director at Novotech Clinical Research (Malaysia) Sdn.
Bhd.
since 2015, Novotech Clinical Research India Pvt Ltd. since 2017, Novotech Aus Holdco Pty Ltd. since 2017, Novotech Clinical Research Usa, Inc. since 2014, Novotech Clinical Research Pte Ltd. since 2014, Clinical Network Services Usa, Inc. since 2018, Novotech New Zealand Ltd. since 2016, Novotech Clinical Research Hong Kong Ltd. since 2016, Novotech Smo Pty Ltd. since 2016, Novotech Asia Korea Co. Ltd. since 2017, Novotech Korea Smo Co. Ltd. since 2017, Novotech Clinical Research Taiwan Pty Ltd. since 2014, Australasian Contract Research Pty Ltd. since 2018, Clinical Network Services Cns Pty Ltd., Novotech Clinical Research Thailand Ltd. since 2020, Clinical Network Services Ltd. since 2018, Novotech Shanghai Ltd. since 2014, and Novotech Holdings Thailand Ltd. since 2016.
.
Former roles include Chief Executive Officer at Novotech (Australia) Pty Ltd. from 2017 to 2026, Chief Executive Officer & Director at Novotech Holdings Pty Ltd. from 2014 to 2026, Chief Executive Officer & Executive Director at Novotech Health Holdings Ltd. from 2020 to 2026, Managing Director at IVF Australia Pty Ltd., Managing Director at Queensland Fertility Group Pty Ltd., Director at Virtus Health Ltd., Project Leader at The Boston Consulting Group Pty Ltd., and Senior Engagement Manager at Partners in Performance International Pty Ltd. Education includes an MBA from the University of Oxford in 2003, a doctorate from Auckland University in 1998, and an undergraduate degree from the University of Canterbury in 1993.